HGXCX
Price
$15.41
Change
-$0.27 (-1.72%)
Updated
Feb 21 closing price
Net Assets
266.05M
RSLDX
Price
$68.20
Change
-$1.55 (-2.22%)
Updated
Feb 21 closing price
Net Assets
74.42B
Ad is loading...

HGXCX vs RSLDX

Header iconHGXCX vs RSLDX Comparison
Open Charts HGXCX vs RSLDXBanner chart's image
Hartford Global Impact C
Price$15.41
Change-$0.27 (-1.72%)
VolumeN/A
Net Assets266.05M
American Funds SMALLCAP World R5E
Price$68.20
Change-$1.55 (-2.22%)
VolumeN/A
Net Assets74.42B
HGXCX vs RSLDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGXCX vs. RSLDX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGXCX is a Hold and RSLDX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 74.4B vs. HGXCX (266M). RSLDX pays higher dividends than HGXCX: RSLDX (0.83) vs HGXCX (0.00). HGXCX was incepted earlier than RSLDX: HGXCX (8 years) vs RSLDX (9 years). HGXCX is a more actively managed with annual turnover of: 34.00 vs. RSLDX (29.00). RSLDX has a lower initial minimum investment than HGXCX: RSLDX (250) vs HGXCX (2000). HGXCX annual gain was more profitable for investors over the last year : 10.39 vs. RSLDX (1.77). HGXCX return over 5 years is better than : 26.62 vs. RSLDX (14.19).
HGXCXRSLDXHGXCX / RSLDX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD3.0770.1621,905%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets266M74.4B0%
Annual Yield % from dividends0.000.83-
Returns for 1 year10.391.77585%
Returns for 3 years7.461.70438%
Returns for 5 years26.6214.19188%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MARUY151.330.47
+0.31%
Marubeni Corp.
CIHKY28.54-0.64
-2.19%
China Merchants Bank Co., Ltd.
PVCT0.11N/A
-2.62%
Provectus Biopharmaceuticals, Inc.
EKTAY5.60-0.49
-8.05%
Elekta AB
IVPAF10.52-1.38
-11.60%
Ivanhoe Mines Ltd.